Growth Metrics

Insight Molecular Diagnostics (IMDX) Tax Provisions (2020 - 2021)

Insight Molecular Diagnostics' Tax Provisions history spans 2 years, with the latest figure at -$97000.0 for Q4 2021.

  • On a quarterly basis, Tax Provisions fell 161.01% to -$97000.0 in Q4 2021 year-over-year; TTM through Sep 2024 was -$97000.0, a N/A change, with the full-year FY2022 number at -$8.1 million, up 12.9% from a year prior.
  • Tax Provisions hit -$97000.0 in Q4 2021 for Insight Molecular Diagnostics, up from -$1.8 million in the prior quarter.
  • Over the last five years, Tax Provisions for IMDX hit a ceiling of $1.1 million in Q1 2020 and a floor of -$7.6 million in Q1 2021.